NHS England reprimanded over Palantir data access omission

NHS England has faced criticism for not disclosing that staff from the controversial tech firm Palantir had been granted "unlimited access" to sensitive, identifiable patient data. This move has raised significant privacy concerns and sparked debates about data security and the ethical use of patient information. The reprimand underscores the importance of transparency in how healthcare data is managed and highlights the potential risks when private companies are given extensive access to such sensitive information. For those invested in healthcare policy and data security, this incident underscores the need for stricter oversight and clearer communication about data access practices.